Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Completed 11Unknown 5Active not recruiting 4Terminated 3Recruiting 2Withdrawn 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 73Head & Neck 51Genitourinary 51Thoracic 48CNS 42Breast 24Gynecologic 13Sarcoma 12Lymphoid 10Tumor-Agnostic 7Dermatologic 5Plasma cell 3Other solid neoplasm 2Other hematologic neoplasm 2Other 2Myeloid 1

Conditions

Solid Tumor 1Rectal Adenocarcinoma with Mismatch-repair Deficient (dMMR)/ Microsatellite Instability-high (MSI-H) 1

Interventions

Injections 54pembrolizumab 39Carboplatin 20Bevacizumab 19Cyclophosphamide 18toripalimab 15tislelizumab 14fludarabine 14Nivolumab 14Cisplatin 14Specimen Handling 13Paclitaxel 13Interviews as Topic 13Pemetrexed 12Standard of Care 11Practice Guidelines as Topic 11Oxaliplatin 11Cetuximab 11Fluorouracil 10atezolizumab 9Educational Status 9Docetaxel 9Capecitabine 9Leucovorin 8Methods 7Etoposide 7Early Intervention, Educational 7spartalizumab 6olaparib 6Ipilimumab 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Radiotherapy × Other solid neoplasm × Clear all
NCT06349837 2026-05-01

Safety and Tolerability of LDRT Plus Concurrent Partial SBRT and Tislelizumab in Patients With Bulky Tumors

Sichuan University

Phase 1 Recruiting
24 enrolled
Other solid neoplasm

Solid Tumor

NCT06762405 2025-02-18

PREDIR-NEOREC

Centre Hospitalier Universitaire Dijon

Phase 3 Recruiting
68 enrolled
GastrointestinalOther solid neoplasm

Rectal Adenocarcinoma with Mismatch-repair Deficient (dMMR)/ Microsatellite Instability-high (MSI-H)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡